当前位置: X-MOL 学术J. Biopharm. Stat. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Estimation on conditional restricted mean survival time with counting process
Journal of Biopharmaceutical Statistics ( IF 1.2 ) Pub Date : 2020-09-06 , DOI: 10.1080/10543406.2020.1814799
Junshan Qiu 1 , Dali Zhou 2 , H M Jim Hung 3 , John Lawrence 2 , Steven Bai 2
Affiliation  

ABSTRACT

In a comparative longitudinal clinical study, multiple clinical events of interest are typically collected in timing and occurrence during the follow-up period. These clinical events are often indicative of disease burden over the study period and provide overall evidence of benefit/risk of one treatment relative to another. While these clinical events are usually used to form a composite endpoint, only the first occurrence of the composite endpoint event is considered in primary efficacy analysis. This type of analysis is commonly performed but it may not be ideal. Most of the existing methods for analyzing multiple event-time data were developed, relying on certain model assumptions. However, the assumptions may greatly affect the inferences for treatment effect. In this paper, we propose a simple, non-parametric estimator of conditional mean survival time for multiple events to quantify treatment effect which has clinically meaningful interpretation. We use simulation studies to evaluate the performance of the new method. Further, we apply this method to analyze the data from a cardiovascular clinical trial as an illustration.



中文翻译:

带计数过程的条件限制平均生存时间估计

摘要

在比较纵向临床研究中,通常在随访期间收集多个感兴趣的临床事件的时间和发生率。这些临床事件通常表明研究期间的疾病负担,并提供一种治疗相对于另一种治疗的益处/风险的总体证据。虽然这些临床事件通常用于形成复合终点,但在主要疗效分析中只考虑复合终点事件的第一次发生。这种类型的分析很常见,但可能并不理想。大多数用于分析多个事件时间数据的现有方法都是依赖于某些模型假设而开发的。然而,这些假设可能会极大地影响对治疗效果的推断。在本文中,我们提出了一个简单的,多个事件的条件平均生存时间的非参数估计量,以量化具有临床意义解释的治疗效果。我们使用模拟研究来评估新方法的性能。此外,我们应用这种方法来分析来自心血管临床试验的数据作为说明。

更新日期:2020-09-06
down
wechat
bug